Consumer Staples Weekly Scan: Monster Beverage Outperforms, Estée Lauder and Constellation Brands Lag Behind

Consumer staples stocks saw mixed results last week, with Monster Beverage leading gains and Estée Lauder and Constellation Brands lagging behind. The market's performance was influenced by expectations of a potential Federal Reserve interest rate cut, with all three major indices closing in the green.

Consumer staples stocks saw mixed results last week, with Monster Beverage leading gains and Estée Lauder and Constellation Brands lagging behind. The market's performance was influenced by expectations of a potential Federal Reserve interest rate cut, with all three major indices closing in the green.

Clorox (CLX) shares rose by 7.71%, outperforming in the consumer staples sector. Analysts project an average price target of $138.01, signaling an 8.64% potential upside. The current consensus recommendation is "Hold" with a GF Value estimate suggesting a 7.36% upside Clorox (CLX) Leads Weekly Gains in Consumer Staples Sector^[1].

Monster Beverage Corporation (MNST) saw its stock surge following a blowout earnings report and a Pepsi deal. The company's EPS for the latest quarter was $0.52, exceeding analyst expectations, with revenue up by 11.1% compared to the previous year. Several large investors, including Intech Investment Management LLC, Pinnacle Associates Ltd., and Migdal Insurance & Financial Holdings Ltd., increased their holdings in Monster Beverage Intech Investment Management LLC Increases Position in Monster Beverage Corporation $MNST^[2].

Estée Lauder (EL) and Constellation Brands (STZ) underperformed last week, with Estée Lauder facing challenges in its luxury beauty segment and Constellation Brands dealing with headwinds in the alcohol beverage market.

The market's performance was influenced by expectations of a potential Federal Reserve interest rate cut. Analysts believe that a rate cut in September could boost consumer spending and economic growth, positively impacting consumer staples stocks.

Caxton Associates LLP acquired a new position in The Clorox Company, purchasing 3,941 shares valued at approximately $580,000 during the 1st quarter of 2023. Clorox's recent earnings reported $2.87 EPS, surpassing estimates, with a revenue increase of 4.5% year-over-year, leading to a positive outlook for fiscal year 2026. The company announced a quarterly dividend of $1.24, representing a 4.0% yield 3,941 Shares in The Clorox Company $CLX Acquired by Caxton Associates LLP^[3].